Genetic Testing Recommendations for Triple Negative Breast Cancer

This research article discusses the need for broader genetic testing guidelines for Triple Negative Breast Cancer (TNBC). A study involving 10,901 women highlights the importance of multigene panel testing beyond BRCA1/2 to identify additional germline mutations associated with TNBC, which could improve patient management and outcomes. The findings suggest that all women with TNBC, regardless of age or family history, should be considered for comprehensive genetic testing.